JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3676
PUT
Kimberly-Clark
KMB
$32.3B
| $1.34M | ﹤0.01% |
9,900
| – | – |
2022 Q1
3 quarters
|
|
|
USDP
3677
DELISTED
USD PARTNERS LP
USDP
| $1.34M | ﹤0.01% |
423,713
-52,114
| -11% | -$198K |
2018 Q4
16 quarters
|
|
|
EXAS
3678
PUT
DELISTED
Exact Sciences
EXAS
| $1.34M | ﹤0.01% |
27,000
+20,300
| +303% | +$829K |
2022 Q1
3 quarters
|
|
3679
Recursion Pharmaceuticals
RXRX
$2.37B
| $1.34M | ﹤0.01% |
173,336
-7,802
| -4% | -$76.5K |
2021 Q2
6 quarters
|
|
3680
Orrstown Financial Services
ORRF
$805M
| $1.33M | ﹤0.01% |
57,301
+37,676
| +192% | +$963K |
2017 Q4
20 quarters
|
|
|
RSX
3681
DELISTED
VanEck Russia ETF
RSX
| $1.32M | ﹤0.01% |
234,535
-350
| -0.1% | -$1.98K |
2014 Q3
33 quarters
|
|
3682
BlackRock Floating Rate Income Strategies Fund
FRA
$365M
| $1.32M | ﹤0.01% |
117,548
+13,883
| +13% | +$159K |
2017 Q4
20 quarters
|
|
3683
iShares International Equity Factor ETF
INTF
$3.67B
| $1.32M | ﹤0.01% |
+53,774
| New | +$1.26M |
2022 Q4
0 quarters
|
|
|
DOZR
3684
DELISTED
Direxion Daily US Infrastructure Bull 2X Shares
DOZR
| $1.32M | ﹤0.01% |
50,000
| – | – |
2021 Q3
5 quarters
|
|
3685
PUT
XPeng
XPEV
$9.15B
| $1.32M | ﹤0.01% |
133,000
+88,400
| +198% | +$797K |
2022 Q3
1 quarter
|
|
3686
Sotera Health
SHC
$5.13B
| $1.32M | ﹤0.01% |
158,456
-334,848
| -68% | -$2.5M |
2020 Q4
8 quarters
|
|
|
ONT
3687
Onterris Inc
ONT
$499M
| $1.32M | ﹤0.01% |
29,688
+2,816
| +10% | +$119K |
2020 Q3
9 quarters
|
|
3688
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.8B
| $1.32M | ﹤0.01% |
45,403
+17,510
| +63% | +$513K |
2020 Q3
9 quarters
|
|
3689
Occidental Petroleum Corp Warrants
OXY.WS
$34B
| $1.32M | ﹤0.01% |
+64
| New | +$2.96K |
2020 Q3
9 quarters
|
|
3690
Tennant Co
TNC
$1.13B
| $1.31M | ﹤0.01% |
21,308
-5,256
| -20% | -$321K |
2013 Q2
38 quarters
|
|
|
EXAS
3691
CALL
DELISTED
Exact Sciences
EXAS
| $1.31M | ﹤0.01% |
+26,500
| New | +$1.08M |
2022 Q4
0 quarters
|
|
3692
Telkom Indonesia
TLK
$12.9B
| $1.31M | ﹤0.01% |
54,929
+10,220
| +23% | +$266K |
2013 Q2
38 quarters
|
|
3693
Milestone Pharmaceuticals
MIST
$94.6M
| $1.31M | ﹤0.01% |
329,724
+276,049
| +514% | +$1.45M |
2021 Q4
4 quarters
|
|
|
TA
3694
DELISTED
TravelCenters of America LLC
TA
| $1.3M | ﹤0.01% |
29,116
+10,196
| +54% | +$528K |
2021 Q1
7 quarters
|
|
|
CASA
3695
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $1.3M | ﹤0.01% |
476,689
+155,654
| +48% | +$457K |
2018 Q1
19 quarters
|
|
3696
Invesco Senior Income Trust
VVR
$442M
| $1.29M | ﹤0.01% |
338,223
-110,439
| -25% | -$420K |
2013 Q2
38 quarters
|
|
3697
CALL
Campbell Soup
CPB
$5.67B
| $1.29M | ﹤0.01% |
22,800
+17,300
| +315% | +$908K |
2021 Q1
7 quarters
|
|
3698
WisdomTree International Equity Fund
DWM
$647M
| $1.29M | ﹤0.01% |
27,472
+27,253
| +12,444% | +$1.22M |
2022 Q2
2 quarters
|
|
|
FINV
3699
FinVolution Group
FINV
$689M
| $1.29M | ﹤0.01% |
260,385
+129,867
| +100% | +$610K |
2017 Q4
20 quarters
|
|
3700
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.71B
| $1.29M | ﹤0.01% |
15,720
+108
| +0.7% | +$8.83K |
2018 Q4
16 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.